Ivy Rx vs MEDVi

MEDVi has an open FDA warning letter dated February 20, 2026. Ivy Rx has none. On compounded semaglutide injection, Ivy Rx costs $24 less a year at standing rates: $197 a month against $199 a month at MEDVi.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Ivy Rx / MEDVi

Ivy Rx logo

Ivy Rx

7.3/10

MEDVi logo

MEDVi

7.7/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$197/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither Ivy Rx nor MEDVi pays us. Links to them earn nothing. Scores: Ivy Rx 7.3, MEDVi 7.7. How we are paid

What the record shows

  1. 01

    MEDVi has an open FDA warning letter dated February 20, 2026. Ivy Rx has none.

  2. 02

    MEDVi names three pharmacies, all 503A. Ivy Rx names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Ivy Rx costs $24 less a year at standing rates: $197 a month against $199 a month at MEDVi.

  4. 04

    Only Ivy Rx lists a price for compounded tirzepatide injection.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Ivy Rx

MEDVi

Compounded semaglutide injection

$197/moLower

$2,364 a year

$199/mo

$2,388 a year

Compounded tirzepatide injection

$297/mo

$3,564 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None; billed monthly
Refunds
All transactions are final; no returns
Full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed
Early-exit fee
None stated
None stated

Read off each seller’s own pages. Ivy Rx: July 10, 2026. MEDVi: October 25, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Ivy Rx

7.3/10
  • No FDA warning letter on record
  • $24 a year less on compounded semaglutide injection
  • Sells compounded tirzepatide injection, which MEDVi does not price
  • Names no compounding pharmacy

The case for MEDVi

7.7/10
  • Names its compounding pharmacy
  • Open FDA warning letter, February 20, 2026

Scores

Ivy Rx 7.3 · MEDVi 7.7 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
6.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
8.5

The score is the same formula for every seller. Payment does not enter it. Method

Ivy Rx vs MEDVi: questions

MEDVi has an open FDA warning letter dated February 20, 2026. Ivy Rx has none. Letters are matched to a seller by company, domain and address, never by a similar name.
MEDVi names three pharmacies, all 503A. Ivy Rx names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Ivy Rx, by $24 a year at standing rates. Ivy Rx: $197 a month, about $2,364 a year. MEDVi: $199 a month, about $2,388 a year.
Ivy Rx states you can cancel at any time; refunds: all transactions are final; no returns. MEDVi states you can cancel at any time; refunds: full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed.
Neither Ivy Rx nor MEDVi pays us. Links to them earn nothing. Scores: Ivy Rx 7.3, MEDVi 7.7.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register